FDA Never Inspected Chinese Plant Making Baxter’s Heparin
A Chinese manufacturing plant that was never inspected by the U.S. Food and Drug Administration could be the source of a potentially deadly allergic reaction experienced by hundreds of U.S. patients infused with Baxter International Inc.'s blood thinner heparin.